UPDATE: Jefferies Assumes Coverage on OraSure Technologies at Buy on Weaker Demand Trend Concerns

In a report published Friday, Jefferies analyst Brandon Couillard assumed coverage on OraSure Technologies OSUR with a Buy rating, but lowered the price target from $12.00 to $8.00.

In the report, Jefferies noted, “Concerns around weaker demand trends in OSUR's legacy product franchises have contributed to precipitous multiple compression, which we view as overdone. Following a better 1Q13 experience, evidence of incremental base business stability should work to rekindle investor enthusiasm for its intermediate-term growth opportunities. With OSUR's new OTC HIV & rapid HCV tests still in their infancy, we assume coverage at Buy / $8 target.”

OraSure Technologies closed on Thursday at $4.47.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorInitiationAnalyst RatingsBrandon CouillardJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!